Sartorius Stedim Biotech SA Financials

Market Capitalization €19.82 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	121.25
Forward PE	47.26
Price to Sales TTM	€7.25
Price to Book MRQ	€5.12
Enterprise to Revenue	8.06
Enterprise to EBITDA	34.13

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	5.87%
Operating Margin	10.79%
Return on Assets TTM	3.13%
Return on Equity TTM	5.02%

Income Statement

Revenue TTM	€2,735,500,032
Revenue per Share TTM	€28.66
Quarterly Revenue Growth	-1.70%
Gross Profit TTM	€1,185,400,064
EBITDA	€579,500,000
Net Income to Common TTM	€160,600,000
Diluted EPS TTM	€1.68
Quarterly Earnings Growth YoY	-0.80%

Balance Sheet

Total Cash MRQ	€482,600,000
Total Cash per Share MRQ	€4.92
Total Debt MRQ	€
Total Debt to Equity MRQ	71.89
Current Ratio MRQ	2.14
Book Value per Share MRQ	€39.78

Cash Flow

Operating Cash Flow TTM	€866,300,032
Levered Free Cash Flow TTM	€221,750,000

DIM Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	97,299,800
Float Shares	29,698,673
Avg 10 Volume	54,009
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	69.71%
% Held by Institutions	11.62%

Stock Price Summary

Beta	0.67
Fifty Two Week Low	€139.10
Fifty Two Week High	€281.00
Fifty Two Week Change	-14.83%
Day 50 MA	€185.58
Day 200 MA	€184.36

Dividends and Splits

Forward Annual Dividend Rate	€2.76
Forward Annual Dividend Yield	1.32%
Trailing Annual Dividend Rate	€0.69
Trailing Annual Dividend Yield	0.33%
Payout Ratio	41.07%
Dividend Date
Ex Dividend Date	2024-04-02
Last Split Factor
Last Split Date	2016-05-06